Sensus Healthcare, Inc. (SRTS)
USD 7.4
(-4.88%)
USD 7.4
(-4.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.14 Million | -1.41 Million | -286 Thousand | -434.18 Thousand | -2.1 Million | -8.56 Million |
| Net Income | 485 Thousand | 24.24 Million | 4.11 Million | -6.83 Million | -1.7 Million | -2.02 Million |
| Depreciation & Amortization | 412 Thousand | 315 Thousand | 613 Thousand | 721.86 Thousand | 545.71 Thousand | 658.25 Thousand |
| Deferred income taxes | -427 Thousand | -1.71 Million | 743 Thousand | 319.73 Thousand | - | - |
| Stock-based compensation | 328 Thousand | 187 Thousand | 415 Thousand | 386 Thousand | 620.92 Thousand | 982.62 Thousand |
| Change in working capital | -3.56 Million | -12.73 Million | -6.13 Million | 5.56 Million | -2.3 Million | -8.29 Million |
| Other non-cash items | 617 Thousand | -11.71 Million | -38 Thousand | -588.01 Thousand | 728.91 Thousand | 108.52 Thousand |
| Investing Cash Flow | -187 Thousand | 14.84 Million | 129 Thousand | 7.03 Million | -4.89 Million | -2.64 Million |
| Investments in PPE | -229 Thousand | -159 Thousand | -128 Thousand | -358.54 Thousand | -400.59 Thousand | -854.83 Thousand |
| Acquisitions | 42 Thousand | 15 Million | 257 Thousand | - | 4.89 Billion | 2.64 Billion |
| Investment purchases | - | - | - | - | -7.79 Million | -2.89 Million |
| Sales/Maturities of investments | - | - | - | 7.38 Million | 3.3 Million | 1.1 Million |
| Other Investing Activities | 42 Thousand | 15 Million | 257 Thousand | 7.38 Million | -4.89 Billion | -2.64 Billion |
| Financing Cash Flow | -40 Thousand | -2.42 Million | -231 Thousand | 210 Thousand | 2.62 Million | 13.6 Million |
| Debt repayment | - | -51 Thousand | -216 Thousand | -266.77 Thousand | - | -2.21 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -27 Thousand | -2.99 Million | -15 Thousand | -57 Thousand | -118.75 Thousand | -118.64 Thousand |
| Common Stock Issuance | 46 Thousand | 731 Thousand | - | 560.00 | 2.73 Million | 17.24 Million |
| Other Financing Activities | -59 Thousand | 622 Thousand | -15 Thousand | 743.56 Thousand | -118.75 Thousand | -3.64 Million |
| Accounts receivables | 6.64 Million | -5.31 Million | -8.43 Million | 10.24 Million | -1.21 Million | -8.17 Million |
| Accounts payables | -2.72 Million | 799 Thousand | 405 Thousand | -2.5 Million | -193.25 Thousand | -85.67 Thousand |
| Inventory | -8.57 Million | -3.19 Million | 2.73 Million | -1.42 Million | -1.69 Million | -661.41 Thousand |
| Other working capital | 1.09 Million | -5.02 Million | -846 Thousand | -756.11 Thousand | 804.91 Thousand | 631.12 Thousand |
| Cash at beginning of period | 25.52 Million | 14.51 Million | 14.9 Million | 8.1 Million | 12.48 Million | 10.08 Million |
| Cash at end of period | 23.14 Million | 25.52 Million | 14.51 Million | 14.9 Million | 8.1 Million | 12.48 Million |
| Capital Expenditure | -229 Thousand | -159 Thousand | -128 Thousand | -358.54 Thousand | -400.59 Thousand | -854.83 Thousand |
| Effect of forex changes on cash | -26.17 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -2.37 Million | 11 Million | -388 Thousand | 6.8 Million | -4.38 Million | 2.39 Million |
| Free Cash Flow | -2.37 Million | -1.57 Million | -414 Thousand | -792.72 Thousand | -2.5 Million | -9.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.61 Million | 2.27 Million | 4.21 Million | 485 Thousand | -1.45 Million | -380 Thousand |
| Depreciation & Amortization | 79 Thousand | 118 Thousand | 106 Thousand | 412 Thousand | 199 Thousand | 83 Thousand |
| Deferred income taxes | -331 Thousand | 827 Thousand | 1 Million | -427 Thousand | -125 Thousand | -501 Thousand |
| Stock-based compensation | 65 Thousand | 91 Thousand | 52 Thousand | 328 Thousand | 67 Thousand | 66 Thousand |
| Change in working capital | 2.72 Million | -11.64 Million | -2.98 Million | -3.56 Million | 1.75 Million | 1.35 Million |
| Other non-cash items | -2.41 Million | 11.41 Million | 285 Thousand | 617 Thousand | 2000.00 | 118 Thousand |
| Investing Cash Flow | -3000.00 | -233 Thousand | 187 Thousand | -187 Thousand | 31 Thousand | -29 Thousand |
| Investments in PPE | -3000.00 | -233 Thousand | 229 Thousand | -229 Thousand | -11 Thousand | -29 Thousand |
| Acquisitions | - | - | -42 Thousand | 42 Thousand | 42 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -233 Thousand | - | 42 Thousand | 42 Thousand | - |
| Financing Cash Flow | 17 Thousand | - | -7000.00 | -40 Thousand | -39 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 40 Thousand | -27 Thousand | -27 Thousand | - |
| Common Stock Issuance | 17 Thousand | - | -46 Thousand | 46 Thousand | - | - |
| Other Financing Activities | 17 Thousand | - | -7000.00 | -59 Thousand | -12 Thousand | - |
| Accounts receivables | 1.29 Million | -8.98 Million | -3.76 Million | 6.64 Million | 2.26 Million | 3.58 Million |
| Accounts payables | -419 Thousand | 910 Thousand | -1.2 Million | -2.72 Million | 58 Thousand | -987 Thousand |
| Inventory | 1.84 Million | -2.86 Million | 1.24 Million | -8.57 Million | -3.17 Million | -3.78 Million |
| Other working capital | 13 Thousand | -712 Thousand | 748 Thousand | 1.09 Million | 2.6 Million | 2.54 Million |
| Cash at beginning of period | 14.72 Million | 23.14 Million | 20.48 Million | 25.52 Million | 20.05 Million | 19.34 Million |
| Cash at end of period | 18.97 Million | 14.72 Million | 23.14 Million | 23.14 Million | 20.48 Million | 20.05 Million |
| Capital Expenditure | -3000.00 | -233 Thousand | 229 Thousand | -229 Thousand | -11 Thousand | -29 Thousand |
| Effect of forex changes on cash | - | - | - | -26.17 Million | - | - |
| Net cash flow / Change in cash | 4.24 Million | -8.42 Million | 2.66 Million | -2.37 Million | 434 Thousand | 713 Thousand |
| Free Cash Flow | 4.22 Million | -8.41 Million | 2.89 Million | -2.37 Million | 431 Thousand | 713 Thousand |
ADVENZYMES
0QYE
KOKUYOCMLN
OIIIF
AHLUCONT
2360